{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:26Z","timestamp":1740107726330,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004833","name":"State of New Jersey Commission on Science and Technology","doi-asserted-by":"crossref","award":["Z191100006619012"],"award-info":[{"award-number":["Z191100006619012"]}],"id":[{"id":"10.13039\/100004833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10067-021-05816-2","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T04:26:56Z","timestamp":1635654416000},"page":"757-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progranulin correlated with rapid progressive interstitial lung disease in dermatomyositis with anti-melanoma differentiation-associated gene 5 antibody"],"prefix":"10.1007","volume":"41","author":[{"given":"Li","family":"Shanshan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Yamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Guochun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,31]]},"reference":[{"key":"5816_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J (2020) Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol 82:267\u2013281","journal-title":"J Am Acad Dermatol"},{"key":"5816_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jaad.2017.12.010","volume":"78","author":"DJB Kurtzman","year":"2018","unstructured":"Kurtzman DJB, Vleugels RA (2018) Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol 78:776\u2013785","journal-title":"J Am Acad Dermatol"},{"key":"5816_CR3","doi-asserted-by":"publisher","first-page":"26552","DOI":"10.18632\/oncotarget.15716","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Wang Q, Yang F, Wu C, Chen S, Wen X et al (2017) Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis. Oncotarget 8:26552\u201326564","journal-title":"Oncotarget"},{"key":"5816_CR4","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","volume":"39","author":"K Huang","year":"2019","unstructured":"Huang K, Vinik O, Shojania K, Yeung J, Shupak R, Nimmo M et al (2019) Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review. Rheumatol Int 39:1971\u20131981","journal-title":"Rheumatol Int"},{"key":"5816_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1189\/jlb.0812429","volume":"93","author":"J Jian","year":"2013","unstructured":"Jian J, Konopka J, Liu C (2013) Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol 93:199\u2013208","journal-title":"J Leukoc Biol"},{"key":"5816_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8559-3_1","volume":"1806","author":"A Bateman","year":"2018","unstructured":"Bateman A, Cheung ST, Bennett HPJ (2018) A brief overview of progranulin in health and disease. Methods Mol Biol 1806:3\u201315","journal-title":"Methods Mol Biol"},{"key":"5816_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cyto.2016.08.007","volume":"101","author":"J Jian","year":"2018","unstructured":"Jian J, Li G, Hettinghouse A, Liu C (2018) Progranulin: a key player in autoimmune diseases. Cytokine 101:48\u201355","journal-title":"Cytokine"},{"key":"5816_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13191","volume":"1383","author":"J Wei","year":"2016","unstructured":"Wei J, Hettinghouse A, Liu C (2016) The role of progranulin in arthritis. Ann N Y Acad Sci 1383:5\u201320","journal-title":"Ann N Y Acad Sci"},{"key":"5816_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/jir.2019.0047","volume":"40","author":"C Jing","year":"2020","unstructured":"Jing C, Zhang X, Song Z, Zheng Y, Yin Y (2020) Progranulin mediates proinflammatory responses in systemic lupus erythematosus: implications for the pathogenesis of systemic lupus erythematosus. J Interferon Cytokine Res 40:33\u201342","journal-title":"J Interferon Cytokine Res"},{"key":"5816_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13075-015-0547-z","volume":"17","author":"A Tanaka","year":"2015","unstructured":"Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M et al (2015) Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis. Arthritis Res Ther 17:27","journal-title":"Arthritis Res Ther"},{"key":"5816_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR et al (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden. The Netherlands Neuromuscul Disord 14:337\u2013345","journal-title":"The Netherlands Neuromuscul Disord"},{"key":"5816_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","volume":"37","author":"J Solomon","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK (2011) Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol 37:100\u2013109","journal-title":"J Bras Pneumol"},{"key":"5816_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00296-015-3372-4","volume":"36","author":"J Chen","year":"2016","unstructured":"Chen J, Li S, Shi J, Zhang L, Li J, Chen S et al (2016) Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity. Rheumatol Int 36:359\u2013364","journal-title":"Rheumatol Int"},{"key":"5816_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1746-1596-8-88","volume":"8","author":"F Qiu","year":"2013","unstructured":"Qiu F, Song L, Ding F, Liu H, Shu Q, Yang N et al (2013) Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus. Diagn Pathol 8:88","journal-title":"Diagn Pathol"},{"key":"5816_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","volume":"332","author":"W Tang","year":"2011","unstructured":"Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY et al (2011) The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332:478\u2013484","journal-title":"Science"},{"key":"5816_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10067-016-3467-7","volume":"36","author":"J Johnson","year":"2017","unstructured":"Johnson J, Yeter K, Rajbhandary R, Neal R, Tian Q, Jian J et al (2017) Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study. Clin Rheumatol 36:507\u2013516","journal-title":"Clin Rheumatol"},{"key":"5816_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.immuni.2011.01.018","volume":"34","author":"B Park","year":"2011","unstructured":"Park B, Buti L, Lee S, Matsuwaki T, Spooner E, Brinkmann MM et al (2011) Granulin is a soluble cofactor for toll-like receptor 9 signaling. Immunity 34:505\u2013513","journal-title":"Immunity"},{"key":"5816_CR18","doi-asserted-by":"publisher","first-page":"R244","DOI":"10.1186\/ar4087","volume":"14","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M et al (2012) Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Arthritis Res Ther 14:R244","journal-title":"Arthritis Res Ther"},{"key":"5816_CR19","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.drudis.2017.06.006","volume":"22","author":"V Abella","year":"2017","unstructured":"Abella V, Pino J, Scotece M, Conde J, Lago F, Gonzalez-Gay MA et al (2017) Progranulin as a biomarker and potential therapeutic agent. Drug Discov Today 22:1557\u20131564","journal-title":"Drug Discov Today"},{"key":"5816_CR20","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1093\/rheumatology\/kez185","volume":"58","author":"Y Horiike","year":"2019","unstructured":"Horiike Y, Suzuki Y, Fujisawa T, Yasui H, Karayama M, Hozumi H et al (2019) Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD. Rheumatology (Oxford) 58:2143\u20132152","journal-title":"Rheumatology (Oxford)"},{"key":"5816_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-016-1214-8","volume":"19","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M et al (2017) Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Arthritis Res Ther 19:9","journal-title":"Arthritis Res Ther"},{"key":"5816_CR22","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.2174\/1381612825666190709202804","volume":"25","author":"J Giemza-Stok\u0142osa","year":"2019","unstructured":"Giemza-Stok\u0142osa J, Islam MA, Kotyla PJ (2019) Hyperferritinaemia: an iron sword of autoimmunity. Curr Pharm Des 25:2909\u20132918","journal-title":"Curr Pharm Des"},{"key":"5816_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","volume":"29","author":"KF Kernan","year":"2017","unstructured":"Kernan KF, Carcillo JA (2017) Hyperferritinemia and inflammation. Int Immunol 29:401\u2013409","journal-title":"Int Immunol"},{"key":"5816_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/14397595.2018.1548918","volume":"29","author":"A Nishioka","year":"2019","unstructured":"Nishioka A, Tsunoda S, Abe T, Yoshikawa T, Takata M, Kitano M et al (2019) Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis. Mod Rheumatol 29:814\u2013820","journal-title":"Mod Rheumatol"},{"key":"5816_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1684\/ejd.2019.3634","volume":"29","author":"SI Motegi","year":"2019","unstructured":"Motegi SI, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M et al (2019) Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease. Eur J Dermatol 29:511\u2013517","journal-title":"Eur J Dermatol"},{"key":"5816_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Kohno N (2012) Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig 50:3\u201313","journal-title":"Respir Investig"},{"key":"5816_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0034-1371527","volume":"35","author":"F Bonella","year":"2014","unstructured":"Bonella F, Costabel U (2014) Biomarkers in connective tissue disease-associated interstitial lung disease. Semin Respir Crit Care Med 35:181\u2013200","journal-title":"Semin Respir Crit Care Med"},{"key":"5816_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/14397595.2018.1553488","volume":"29","author":"M Hanaoka","year":"2019","unstructured":"Hanaoka M, Katsumata Y, Kawasumi H, Kawaguchi Y, Yamanaka H (2019) KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis\/dermatomyositis, but is not a short-term disease-activity biomarker. Mod Rheumatol 29:625\u2013632","journal-title":"Mod Rheumatol"},{"key":"5816_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jcmm.12756","volume":"20","author":"Y Yu","year":"2016","unstructured":"Yu Y, Xu X, Liu L, Mao S, Feng T, Lu Y et al (2016) Progranulin deficiency leads to severe inflammation, lung injury and cell death in a mouse model of endotoxic shock. J Cell Mol Med 20:506\u2013517","journal-title":"J Cell Mol Med"},{"issue":"3.4","key":"5816_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2152\/jmi.65.251","volume":"65","author":"T Kishaba","year":"2018","unstructured":"Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K et al (2018) Clinical characteristics of dermatomyosits\/polymyositis associated interstitial lung disease according to the autoantibody. J Med Invest 65(3.4):251\u2013257","journal-title":"J Med Invest"},{"issue":"1","key":"5816_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12890-017-0479-2","volume":"17","author":"H Okabayashi","year":"2017","unstructured":"Okabayashi H, Ichiyasu H, Hirooka S, Akaike K, Kojima K, Jodai T et al (2017) Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias. BMC Pulm Med 17(1):134","journal-title":"BMC Pulm Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05816-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05816-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05816-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T03:11:58Z","timestamp":1645758718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05816-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5816"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05816-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2021,10,31]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the China-Japan Friendship Hospital. All persons gave their informed consent prior to participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}